Skylark Bio

Cambridge, United States

Skylark Bio is a biotechnology company that develops gene therapies to treat hearing losses.

$40.9M raised

Aug 2022

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Skylark Bio

How much funding has Skylark Bio raised?

Skylark Bio has raised $40.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.

Where is Skylark Bio headquartered?

Skylark Bio is headquartered in Cambridge, United States.

What does Skylark Bio do?

Skylark Bio is a biotechnology company that develops gene therapies to treat hearing losses.

What stage is Skylark Bio at?

Skylark Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 16, 2022.

MLA

"Skylark Bio — Funding & Investors." VCBacked, August 16, 2022, https://www.vcbacked.co/company/skylark-bio. Accessed July 3, 2026.

APA

VCBacked. (2022). Skylark Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/skylark-bio

Wikipedia (cite web)

{{cite web |title=Skylark Bio — Funding & Investors |url=https://www.vcbacked.co/company/skylark-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 16, 2022.